MEDIAN TECHNOLOGIE.EO-05
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more
MEDIAN TECHNOLOGIE.EO-05 (4ZG) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, MEDIAN TECHNOLOGIE.EO-05 (4ZG) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
MEDIAN TECHNOLOGIE.EO-05 - Net Assets Trend (None–None)
This chart illustrates how MEDIAN TECHNOLOGIE.EO-05's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MEDIAN TECHNOLOGIE.EO-05 (None–None)
The table below shows the annual net assets of MEDIAN TECHNOLOGIE.EO-05 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to MEDIAN TECHNOLOGIE.EO-05's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
MEDIAN TECHNOLOGIE.EO-05 Competitors by Market Cap
The table below lists competitors of MEDIAN TECHNOLOGIE.EO-05 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
DHI Group Inc
NYSE:DHX
|
$83.86 Million |
|
Viet Nam Fumigation JSC
VN:VFG
|
$83.88 Million |
|
Pashupati Cotspin Limited
NSE:PASHUPATI
|
$83.89 Million |
|
Webjet Group Ltd
AU:WJL
|
$83.91 Million |
|
Sunjin
KO:136490
|
$83.82 Million |
|
Tuniu Corp
NASDAQ:TOUR
|
$83.80 Million |
|
Ramco Industries Limited
NSE:RAMCOIND
|
$83.78 Million |
|
Kistos Holdings Plc
PINK:KSTOF
|
$83.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MEDIAN TECHNOLOGIE.EO-05's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares MEDIAN TECHNOLOGIE.EO-05's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently MEDIAN TECHNOLOGIE.EO-05 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares MEDIAN TECHNOLOGIE.EO-05's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MEDIAN TECHNOLOGIE.EO-05 (4ZG) | €- | N/A | N/A | $83.83 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |